Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorRenJi Hospital

About this trial

This is a multicenter, prospective, and observational real-world study aimed at investigating the current situation of surgical treatments and prognosis for acute epidural hematoma in China, and analyzing the optimization of therapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clear medical history of traumatic brain injury;

within 12 hours after injury;

Supratentorial unilateral acute epidural hematoma on first head CT scan examination;

The admitting neurosurgeon considers that the epidural hematoma needs to be evacuated with surgical treatment;

Disqualifiers

Previous intracranial surgery prior to trauma;

Patients with a score of 3 on the GCS, with bilateral fixed and dilated pupils, bleeding diathesis or defective coagulation, or an injury that was deemed to be unsurvivable;

CT demonstrates associated other intracranial hematomas e.g. subdural, intracerebral hemorrhage, or large size infarction, which are the main causes of operation;

Patients who had injury of the oculomotor nerve;

Trial population

The population who were diagnosed with acute epidural hematoma and necessary for undergoing evacuation of an acute epidural hematoma.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

GOSE (extended Glasgow Outcome Scale) scores

The primary outcome is indicated by the long-term functional outcomes, including overall mortality and the score on the Extended Glasgow Outcome Scale (GOS-E), "Extended Glasgow Outcome Scale" is the unabbreviated scale title. The minimum value of scale is score 1, and maximum value is scored 8, higher scores mean a better outcome and lower scores mean worse outcome. Specific scored as follows: 1. death; 2. persistent vegetative state; 3. lower severe disability; 4. upper severe disability; (stratum 3 and 4 were considered as severe disability, with permanent requirement for help with daily living); 5. lower moderate disability; 6. upper moderate disability; (stratum 5 and 6 were considered as mild disability, without a need for assistance in everyday life, that might, however, require special equipment for employment); 7. lower good recovery; 8. upper good recovery (stratum 7 and 8 were considered as good recovery).

Time frame
at 6 months post-injury

Secondary outcomes

1

incidence of post-operative cerebral infarction

The incidence of traumatic AEDH post-operative cerebral infarction within 6 months post-injury, which is primarily diagnosed by independent radiologists with CT or MRI examination.

Time frame
within 6 months post-injury
2

incidence of additional craniocerebral surgery

The incidence of additional craniocerebral surgery within 6 months post-injury, related to clinical deterioration after initial surgical treatment of AEDH.

Time frame
within 6 months post-injury
3

length of stay in ICU and hospital

The duration of hospitalization after initial surgery within 6 months post-injury, including ICU and hospital stays.

Time frame
within 6 months post-injury
4

detailed economic evaluation

Total medical expense related to treatment of AEDH, including the costs of operations, hospitalization and rehabilitation within 6 months post-injury.

Time frame
within 6 months post-injury

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

RenJi Hospital

Lead sponsor

Clinical Research Institute, Shanghai Jiao Tong University School of Medicine

Collaborator

Shenzhen Second People's Hospital

Collaborator